Novavax, Inc. (NVAX) Social Stream



Novavax, Inc. (NVAX): $51.85

0.79 (+1.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NVAX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Novavax Inc (NVAX) Price Targets From Analysts

Use the tables below to see what analysts covering Novavax Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 6 $305 $200 $266.2 $78.83 237.69%
2021-12-16 6 $305 $172 $260.6 $78.83 230.58%
2021-12-21 6 $305 $209 $268 $78.83 239.97%
2022-01-03 6 $315 $209 $270 $78.83 242.51%
2022-01-24 7 $315 $150 $250 $78.83 217.14%
2022-02-14 7 $315 $150 $232 $78.83 194.3%
2022-02-22 7 $315 $150 $223.333 $78.83 183.31%
2022-02-28 7 $294 $150 $215 $78.83 172.74%
2022-03-02 7 $294 $150 $213 $78.83 170.2%
2022-03-03 7 $250 $150 $196 $78.83 148.64%

The Trend in the Analyst Price Target


NVAX's average price target has moved down $92.25 over the prior 42 weeks.

NVAX reports an average of 71% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 2 294 217 258.0 189.79 35.94%
2021-09-11 5 305 200 264.2 242.18 9.09%
2021-09-20 5 305 200 264.2 226.92 16.43%
2022-01-24 6 315 150 250.0 79.47 214.58%
2022-02-22 7 294 150 215.0 79.39 170.81%

NVAX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 5 0 2 0 0 7

The Trend in the Broker Recommendations


Over the past 120 days, NVAX's average broker recommendation rating improved by 0.1.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVAX as an investment opportunity.

  • In the context of all US stocks, Novavax Inc's average analyst price target is higher than 1003.15% of them.
  • Novavax Inc's upside potential (average analyst target price relative to current price) is higher than 975.44% of all US stocks.
  • In terms of how Novavax Inc fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 151.19% of that group.
  • NVAX has a lower variance in analysts' estimates than -671.44% of stocks in the large market cap category.

In the Pharmaceutical Products industry, NBIX, MRNA, and GILD are the three stocks most similar to Novavax Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NVAX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4632 seconds.